Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival
Erika Hissong , Bhavneet Bhinder , Junbum Kim , Kentaro Ohara , Hiranmayi Ravichandran , Majd Al Assaad , Sarah Elsoukkary , Michael Shusterman , Uqba Khan , Kenneth Wha Eng , Rohan Bareja , Jyothi Manohar , Michael Sigouros , Andre F. Rendeiro , Jose Jessurun , Allyson J. Ocean , Andrea Sboner , Olivier Elemento , Juan Miguel Mosquera , Manish A. Shah
{"title":"Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival","authors":"Erika Hissong , Bhavneet Bhinder , Junbum Kim , Kentaro Ohara , Hiranmayi Ravichandran , Majd Al Assaad , Sarah Elsoukkary , Michael Shusterman , Uqba Khan , Kenneth Wha Eng , Rohan Bareja , Jyothi Manohar , Michael Sigouros , Andre F. Rendeiro , Jose Jessurun , Allyson J. Ocean , Andrea Sboner , Olivier Elemento , Juan Miguel Mosquera , Manish A. Shah","doi":"10.1016/j.prp.2025.156150","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Colorectal carcinoma (CRC) is a heterogeneous group of tumors with varying therapeutic response and prognosis, and evidence suggests the tumor immune microenvironment (TIME) plays a pivotal role. Using advanced molecular and spatial biology technologies, we aimed to evaluate the TIME in patients with CRC to determine whether specific characteristics of immune composition correlated with prognosis.</div></div><div><h3>Methods</h3><div>We identified primary and metastatic tumor samples from 31 consented patients, which were profiled with whole-exome sequencing and bulk RNA-seq. Immune cell deconvolution followed by gene set enrichment analysis and unsupervised clustering was performed. A subset of tumors underwent <em>in situ</em> analysis of the TIME spatial composition at single-cell resolution through Imaging Mass Cytometry.</div></div><div><h3>Results</h3><div>Gene set enrichment analysis revealed two distinct groups of advanced CRC, one with an immune activated phenotype and the other with a suppressed immune microenvironment. The activated TIME phenotype contained increased Th1 cells, activated dendritic cells, tertiary lymphoid structures, and higher counts of CD8 + T cells whereas the inactive or suppressed TIME contained increased macrophages enriched for immunosuppressive M2 macrophages. Our findings were further supported by RNA-seq data analysis from the TCGA CRC database, in which the ratio of inactivated to activated dendritic cells within the CRC TIME correlated with a lower overall survival probability (HR 1.66, p = 0.007).</div></div><div><h3>Conclusion</h3><div>We identified distinct immunologic tumor microenvironments in colorectal cancer. Cancers harboring an activated TIME are associated with improved survival. Identifying key molecular drivers of the CRC TIME may offer opportunities to improve patient survival.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"273 ","pages":"Article 156150"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology, research and practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0344033825003437","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Colorectal carcinoma (CRC) is a heterogeneous group of tumors with varying therapeutic response and prognosis, and evidence suggests the tumor immune microenvironment (TIME) plays a pivotal role. Using advanced molecular and spatial biology technologies, we aimed to evaluate the TIME in patients with CRC to determine whether specific characteristics of immune composition correlated with prognosis.
Methods
We identified primary and metastatic tumor samples from 31 consented patients, which were profiled with whole-exome sequencing and bulk RNA-seq. Immune cell deconvolution followed by gene set enrichment analysis and unsupervised clustering was performed. A subset of tumors underwent in situ analysis of the TIME spatial composition at single-cell resolution through Imaging Mass Cytometry.
Results
Gene set enrichment analysis revealed two distinct groups of advanced CRC, one with an immune activated phenotype and the other with a suppressed immune microenvironment. The activated TIME phenotype contained increased Th1 cells, activated dendritic cells, tertiary lymphoid structures, and higher counts of CD8 + T cells whereas the inactive or suppressed TIME contained increased macrophages enriched for immunosuppressive M2 macrophages. Our findings were further supported by RNA-seq data analysis from the TCGA CRC database, in which the ratio of inactivated to activated dendritic cells within the CRC TIME correlated with a lower overall survival probability (HR 1.66, p = 0.007).
Conclusion
We identified distinct immunologic tumor microenvironments in colorectal cancer. Cancers harboring an activated TIME are associated with improved survival. Identifying key molecular drivers of the CRC TIME may offer opportunities to improve patient survival.
期刊介绍:
Pathology, Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology: Reviews focus on recent progress in pathology, while Comments look at interesting current problems and at hypotheses for future developments in pathology. Original Papers present novel findings on all aspects of general, anatomic and molecular pathology. Rapid Communications inform readers on preliminary findings that may be relevant for further studies and need to be communicated quickly. Teaching Cases look at new aspects or special diagnostic problems of diseases and at case reports relevant for the pathologist''s practice.